MedPath

Intravacc B.V.

Intravacc B.V. logo
🇩🇰Denmark
Ownership
Private
Established
2012-01-01
Employees
101
Market Cap
-
Website
https://www.intravacc.nl

Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers

Phase 1
Completed
Conditions
COVID-19
Interventions
Other: Placebo
Biological: Avacc 10
First Posted Date
2022-11-03
Last Posted Date
2024-03-22
Lead Sponsor
Intravacc B.V.
Target Recruit Count
40
Registration Number
NCT05604690
Locations
🇦🇺

University of the Sunshine Coast Clinical Trial Centre, Sippy Downs, Queensland, Australia

© Copyright 2025. All Rights Reserved by MedPath